Skip to main content

Table 2 Proportion of patients having each type of SRE in the first 12 months of intravenous bisphosphonate therapy

From: Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer

 

Number of patients

Â¥Proportion with event (%)

Type of SRE

   Pathological fracture

7

9%

   Cord compression

1

1%

   Other

20

23%

Site of SRE

   Vertebral

9

10%

   Non-vertebral

17

22%

   Hypercalcaemia

1

1%

Treatment for SRE

   Radiotherapy

17

21%

   Surgery

3

4%

   Medical+

8

10%

  1. ¥Kaplan-Meier estimates of the proportion with a complication. + Medical includes change in analgesics, hormonal treatment or chemotherapy.